Eli Lily Releases Statement Regarding Tirzepatide Use for Cosmetic Weight Loss
Eli Lilly & Co. has been one of the first companies to address the off-label use of their tirzepatide drugs, Mounjaro and Zepbound, for cosmetic weight loss.
Stay updated with breaking news from Demonstrated Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly & Co. has been one of the first companies to address the off-label use of their tirzepatide drugs, Mounjaro and Zepbound, for cosmetic weight loss.
Wellness NASDAQ Company Expands Distribution in Asia and the Middle East with Newly Acquired Minoxidil (Rogaine(R)) and Photoci(TM) Products: JUPW
Huge NASDAQ Licensing Agreement: $JUPW Licenses Minoxidil Booster to Taisho: Jupiter Wellness, Inc. (NASDAQ: JUPW)
NASDAQ Acquisition & Licensing Agreement: $JUPW Acquires Assets of Applied Biology, then Licenses Minoxidil Booster to Taisho: Jupiter Wellness, NASDAQ: JUPW
JUPW just Acquired a 3 Million Dollar Firm and Started a 5 Million Dollar Share Buyback. JUPW has been Featured on CNN, ABC, CBS, Bloomberg, Vogue & Forbes